Abstract 14451: Switching From Warfarin to Direct Oral Anticoagulants (DOACs) in Medicine Clinic at a Safety Net Hospital in New York City: A Quality Improvement Projectdoi:10.1161/circ.148.suppl_1.14451WarfarinAnticoagulantsQuality improvementDisparitiesIntroduction:Many patients are still using warfarin ...
warfarinPrevious studies examining the use of direct oral anticoagulants (DOACs) in atrial fibrillation (AF) have largely focused on patients newly initiating therapy. Little is known about the prevalence/patterns of switching to DOACs among AF patients initially treated with warfarin.doi:10.1002/clc....
Warfarin remains the most commonly prescribed oral anticoagulant in the United States, but it has disadvantages such as dietary interactions and frequent laboratory monitoring. Direct oral anticoagulants (DOACs) have been introduced as safer and equally effective alternatives to warfarin. This study ...
Warfarin remains the most commonly prescribed oral anticoagulant in the United States, but it has disadvantages such as dietary interactions and frequent laboratory monitoring. Direct oral anticoagulants (DOACs) have been introduced as safer and equally effective alternatives to warfarin. This study ...
Since direct oral anticoagulants (DOACs) have been introduced for treatment and prevention of thromboembolic diseases, patients on vitamin K antagonists (VKA) have to decide whether to remain on VKA or switch to DOAC. The goal of this study was to evaluate treatment satisfaction, preferences, and...
Switching among oral anticoagulants: is it logical?doi:10.1080/03007995.2019.1662196zcan BaaranMurat BitekerTaylor And FrancisCurrent Medical Research & Opinion
Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?doi:10.1111/jth.15592Myrthe M A TooropQingui ChenMarieke J H A KruipFelix J M van der Meer...
Patients with an estimated glomerular filtration rate (eGFR) <30 mL/min were more likely to switch from DOACs to warfarin and less likely to switch from warfarin, compared to those with an eGFR >60 mL/min. Conclusion:There was a low switching rate between OACs in Australian general practice...
Management implications associated with switching from vitamin K antagonist anticoagulants to direct oral anticoagulants.doi:10.1016/j.rec.2021.09.014A.Pia-MorandeiraS.Cinza-SanjurjoM.Portela-RomeroRev Esp Cardiol (Engl Ed)Revista espanola de cardiologia (English ed.)...
of Health, of which 11% (n = 102) were due to AVK intolerance or adverse event, 42% (n = 398) due to poor INR control (48.41 卤 19.5% mean of days in target range), 2% (n = 23) due to impediment in the INR control and 3% (n = 33) due to switching from another NOAC. ...